首页 | 本学科首页   官方微博 | 高级检索  
检索        

谷氨酰胺对肝硬化患者血清TNF-α和IL-6水平的影响
引用本文:项立,胡卫东,龙子义,周永柏,吴东海,龙舟,杨兵.谷氨酰胺对肝硬化患者血清TNF-α和IL-6水平的影响[J].中华全科医学,2012(2):223+300.
作者姓名:项立  胡卫东  龙子义  周永柏  吴东海  龙舟  杨兵
作者单位:广东省深圳市龙岗中心医院消化内科;广东省深圳市龙岗中心医院影像科
摘    要:目的探讨谷氨酰胺(Gln)对肝硬化患者血清肿瘤坏死因子α(TNF-α)和白细胞介素-6(IL-6)水平的影响及临床意义。方法将44例肝硬化患者随机分为两组,对照组给予常规治疗,试验组在此基础上还给予口服L-2谷氨酰胺呱仑酸钠颗粒,治疗时间8周。对比两组患者治疗前后血清TNF-α和IL-6水平、肝功能变化及自发性腹膜炎发生率。结果试验组用Gln后血清TNF-α和IL-6水平明显降低,与对照组相比,差异有统计学意义(P<0.05),肝功能有所改善,自发性腹膜炎发生率降低,但与对照组相比,差异无统计学意义。结论谷氨酰胺可以显著降低肝硬化患者血清TNF-α和IL-6水平,有利于改善肝硬化患者的肝损害及降低并发症的发生。

关 键 词:谷氨酰胺  肝硬化  肿瘤坏死因子α  白细胞介素-6

Effect of Glutamine on Serum Tumor Necrosis Factor-α and Interleukin-6 Levels in Patients with Hepatocirrhosis
Institution:XIANG Li,HU Wei-dong,LONG Zi-yi,et al.Department of Digestion,Shenzhen Longgang Central Hospital,Guangzhou 518172,Guangdong,China
Abstract:Objective To observe the changes in serum tumor necrosis factor-α(TNF-α) and interleukin-6(IL-6) after administration of glutamine(Gln) in patients with hepatocirrhosis.Methods Patients with hepatocirrhosis were randomized equally into 2 groups and received standard treatment.Besides,the trial group was given 8 weeks of Gln administration.The serum TNF-α,IL-6 and hepatic function were detected and spontaneous bacterial peritonitis(SAP) was observed in two groups.Results The serum IL-6 and TNF-α of Gln group decreased significantly(P<0.01) in comparison with those of the control group.In Gln group,the functions of liver were improved and the incidence of SAP was lower,but it has no significance(P>0.05).Conclusion Gln may improve the clinical outcomes of patients with hepatocirrhosis probably by decreasing serum IL-8 and TNF-α.
Keywords:Glutamine  Hepatocirrhosis  Tumor necrosis factor-α  Interleukin-6
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号